|
End-of-day quote
Taipei Exchange
2026-09-22
|
5-day change | 1st Jan Change | ||
| 7.050 TWD | +0.71% |
|
+0.14% | -28.79% |
| 08-12 | Pharmigene, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-28 | Pharmigene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 11.13M | - | - | - | - | - |
| 4.62B | - | ||||
| 4.45B | - | ||||
| 3.34B | |||||
| 2.81B | - | - | |||
| 2.43B | - | - | - | - |
- Stock Market
- Stocks
- 7595 Stock
- Charts Pharmigene, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
